Events

Further to the postponement of our 3rd Annual Network Meeting in Kenya 24-27 March 2020, we have constantly been reviewing the global situation surrounding COVID-19. As a Network focusing on global health our priority must continue along the lines of taking the required precautions to minimize the spread of the virus. Our commitment to deliver […]

The AMR Conference is a platform for subject matter experts (SMEs), start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges in bringing new antimicrobial treatments and diagnostics to the market.

The conference promotes academic and social collaborations among all scientists in the research fields of Pseudomonas – the genus that contains human, animal and plant pathogens as well as biocontrol agents.

Click here to learn more, additional details forthcoming. 

This year's program will include antimicrobial discovery and global trends in AMR, in addition to the focus on genomic evidence and the other tools for surveillance. It will highlight the recent advances in the rapidly emerging field of machine learning and GWAS methods to predict AMR. We will also discuss the role of vaccines in […]

ASM Microbe connects you to a global network of scientists, researchers and health care professionals. Whether it’s presenting your research to peers and luminaries in your field, or accessing the latest science and novel techniques in your area or related discipline, ASM Microbe is the premier forum to share knowledge and collaborate across the full […]

A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and how CARB-X and its partners are working together to address them. The webinar celebrates a recent funding announcement in which BARDA and Wellcome […]

Topic: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, Challenges and Future Development Purpose: Antimicrobial resistance caused 4.95 million deaths associated with AMR and 1.27 million deaths attributable to AMR in 2019. Vaccines can prevent a proportion of the AMR burden by preventing drug-sensitive and drug-resistant infections, reducing antibiotic use and reducing pathogen transmission and […]

The chair is currently developing a description for this conference. Please check back for updates. Click here to learn more.

The chair is currently developing a description for this conference. Please check back for updates. Click here to learn more.